Market Research Logo

Drug Delivery Series: The Market for Advanced Drug Delivery Technology Systems: Volume 5

Drug Delivery Series: The Market for Advanced Drug Delivery Technology Systems: Volume 5

Volume 5 of the Drug Delivery Series will address advanced drug delivery technologies, including such cutting edge technology as liposome drug delivery, polymer and polymeric micelles, micro-particulates, DNA binding, monoclonal antibodies, gene therapy and micro-encapsulation. Emerging technologies are continuing to bring many developmental advances to the pharmaceutical industry.


The Drug Delivery Series

An Innovative NEW Series of Five Reports, Featuring Primary Research & Global Coverage

Drug delivery is one of the most important drivers in the rapidly changing pharmaceutical industry. Each volume of this new series examines an area of drug delivery singly and in depth. Market opportunities, new technologies and products, shifting alliances and licensing deals, important trends, and forecasts through 2005 are covered in each of the five volumes of the series.

Kalorama’s analysts have taken a unique look at the market today and in the future by calculating not only total market size and growth, but also the relative value of the drug delivery component itself as separate from total pharmaceutical sales. This quantitative analysis is extremely instructive and unique to this series of reports.

Anyone involved in the pharmaceutical industry—drug delivery companies or pharmaceutical manufacturers—can turn to this series to examine competitors, extend product life cycles, and learn more about the plethora of advanced drug delivery systems in development that will suit currently available products.

For each of the major delivery routes, the series covers:

  • Market size, segmentation, and growth
  • Market drivers, barriers, and trends
  • Competitive analysis of companies and products—both current and in development
  • Value of drug delivery technology in relation to pharmaceutical products
  • Impact of delivery technology on the viability of new biopharmaceuticals
  • Implications for pharmaceutical sales and marketing
  • Profiles of the major players, including partnerships and alliances
  • International directory of companies involved in the segment

Use These Valuable Reports to:

  • Define and size your target market
  • Capitalize on industry trends
  • Reduce the risk of your business investment
  • Position yourself against your competition
  • Effectively launch new products or enter new markets
  • Create successful marketing and sales strategies
  • Create highly-targeted marketing messages
  • Strengthen brand awareness
  • Identify new revenue opportunities
  • Empower your sales force with the tools they need to succeed

Press Release

Advance Drug Delivery to Top $7 Billion in Revenues

New York, February 27, 2002 /PR Newswire — The market for drugs employing advanced drug delivery technologies is expanding rapidly and will surpass $7 billion by 2005, according to a new study released today from Kalorama Information and available at MarketResearch.com. The segment has seen double-digit growth over the past few years, and the study found that this trend should continue.

Moreover, the study entitled The Market for Advance Drug Delivery Systems, reveals that revenues attributable to the delivery technologies themselves, separate from those attributable to the pharmaceutical component sales, are gaining ground faster than the segment as a whole. In an analysis unique to Kalorama, the study shows that the relative value of advanced delivery technologies will approach half of the total market value by 2005.

“There appear to be several factors driving the expansion,” states Steven Heffner, acquisitions editor at Kalorama Information. “Among them are the growing number of difficult-to-administer biopharmaceuticals, pharma’s ever-increasing demand for sophisticated life-cycle management, and the age-old catchall—because the technologies are there.”

The Market for Advance Drug Delivery Systems is the final volume in a five-volume study of drug delivery technologies conducted over the past year. In addition to the main technologies covered—liposomal, monoclonal antibody-based, and polymer-based technologies—the current report discusses developments in a whole host of newer technologies such as nanoparticles, molecular imprinted polymers, matallofullerenes, prodrug delivery, and others. Other volumes in the series examine oral, injectable and implantable, pulmonary, and transdermal and transmucosal delivery.

Chapter One: Executive Summary


    Market Drivers
    Market Size and Growth
    • Total Advanced Drug Delivery Market
    • The Advanced Drug Delivery Only Market

    Competitive and Market Analysis

Chapter Two: Introduction and Overview


    Introduction
    Scope and Methodology
    Reasons for Advanced Drug Delivery Systems
    Phases of Drug Action
    Liposome Drug Delivery
    • Liposome Targeting

    Polymer Drug Delivery
    • Polymeric Implants
    • Biodegradable Polymers
    • Nano- and Microparticulates
    • Polymer Micelles
    • PEGylation Technology
    • Hydrogel Polymers
    • Colloidal systems

    Monoclonal Antibodies Drug Delivery

Chapter Three: Trends and Developments


    Expansion of Biotechnology
    Incorporation of Technology
    Molecular Imprinted Polymers
    Pharmacoeconomics of Drug Delivery Systems
    Gene Therapy Drug Delivery
    Metallofullerenes
    Antisense Delivery Systems
    Camouflaged Nanoparticles
    Microfabrication
    Thermosetting Biodegradable Polymer
    Triggerable Drug Delivery
    VP22 Drug Delivery
    Prodrug Drug Delivery
    Single Chain Antigen-Binding Protein Technology
    Magnetic Targeted Carriers
    Heat Shock Protein Technology
    Other Emerging Drug Delivery Technologies

Chapter Four: Market Size and Growth

Chapter Five: Competitive and Market Analysis


    Competitive Landscape
    Market Analysis

Chapter Six: Company Profiles


    Alkermes, Inc.
    Alza Corporation
    Andrx Corporation
    Atrix Laboratories, Inc.
    Biovail Corporation
    Centocor, Inc.
    Control Delivery Systems, Inc.
    Elan Corporation, Plc
    EnColl Corporation, Inc.
    Enzon, Inc.
    Gilead Sciences, Inc.
    Guilford Pharmaceuticals, Inc.
    IDEC Pharmaceuticals Corporation
    MacroMed, Inc.
    Protein Design Labs, Inc.

Appendix: Company Directory

List of Exhibits


    Table 2-1: Sequence of Drug Action
    Table 2-2: Marketed Monoclonal Antibodies, 2000
    Table 4-1: The Worldwide Market for Advanced Drug Delivery Systems by Type, 1995-2005
    Table 4-2: The Worldwide Market for Advanced Drug Delivery Systems, Market Share by Type, 1995-2005
    Table 4-3: The Worldwide Market for Advanced Drug Delivery Systems by Pharmaceutical and Drug Delivery Component, 1995-2005
    Table 4-4: The Worldwide Market for Advanced Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005
    Table 5-1: Worldwide Market for Advanced Drug Delivery System, Revenues and Market Share by Supplier, 2000
    Figure 4-1: The Worldwide Market for Advanced Drug Delivery Systems, Revenues by Type, 1995-2005
    Figure 4-2: The Worldwide Market for Advanced Drug Delivery Systems, Share by Type, 2000
    Figure 4-3: The Worldwide Market for Advanced Drug Delivery Systems, Share by Type, 2005
    Figure 4-4: The Worldwide Market for Advanced Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005
    Figure 4-5: The Worldwide Market for Advanced Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2000
    Figure 4-6: The Worldwide Market for Advanced Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2005
    Figure 5-1: Worldwide Market for Advanced Drug Delivery Systems, Market Share by Leading Supplier, 2000

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report